Q1 2021 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2021-05-10 | ||||||
REV |
Q4 2020 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.700 | -0.850 | -0.1500 | ||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
Ticker | Company | Price | Change | Chg % | Mkt Cap | |
---|---|---|---|---|---|---|
PASG | Passage Bio | 19.83 | 0.40 | 2.06% | 1.1B |
You can purchase shares of Passage Bio (NASDAQ: PASG) through any online brokerage.
Other companies in Passage Bio’s space includes: 4D Molecular Therapeutics (NASDAQ:FDMT), Trillium Therapeutics (NASDAQ:TRIL) and Syndax Pharmaceuticals (NASDAQ:SNDX).
The latest price target for Passage Bio (NASDAQ: PASG) was reported by Goldman Sachs on 2021-03-04. The analyst firm set a price target for 30.00 expecting PASG to rise to within 12 months (a possible 51.29% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Passage Bio (NASDAQ: PASG) is $19.83 last updated Fri Mar 05 2021 21:00:02 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Passage Bio.
There is no upcoming split for Passage Bio.